Information Provided By: 
Fly News Breaks for October 26, 2016
EW
Oct 26, 2016 | 07:50 EDT
Canaccord analyst Jason Mills said the expectations for Edwards Lifesciences was set too high and its Q3 results were strong in absolute terms. Mills said the company blew away the last nine quarters and that expectations became too great. He recommends aggressively buying the shares, noting that top line guidance was maintained and bottom line guidance was raised. Mills reiterated his Buy rating and $140 price target on Edwards Lifesciences shares.
News For EW From the Last 2 Days
There are no results for your query EW
